PATENT CLAIM ANALYSIS

Application Number: 16132411
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "261100"]

Abstract:
Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.

Claim (Index 36):
The method of  claim 25 , wherein R is

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15172126', '12997721', '14618829', '13889921', '15682346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798768530231939
- 35 USC 102 Novelty (BERT): 0.5522919517490323
- Combined Prediction Score: 0.7741208723836482
- Mean Citation Score: 421.637286
- Max Citation Score: 441.61008
- Similarity Product: 240.85701709164616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test